NBGEX | VISGX | NBGEX / VISGX | |
Total Expense Ratio | 1.09 | 0.19 | 574% |
Annual Report Gross Expense Ratio | 1.09 | 0.19 | 574% |
Fund Existence | 32 years | 27 years | - |
Gain YTD | -4.165 | 7.310 | -57% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.71B | 39.1B | 22% |
Annual Yield % from dividends | 0.00 | 0.44 | - |
Returns for 1 year | -10.45 | 10.18 | -103% |
Returns for 3 years | 4.73 | 49.62 | 10% |
Returns for 5 years | -4.09 | 31.06 | -13% |
Returns for 10 years | 8.62 | 147.79 | 6% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNSX | 71.60 | 0.44 | +0.62% |
Janus Henderson Global Life Sciences S | |||
SSCOX | 6.15 | 0.03 | +0.49% |
Touchstone Small Company C | |||
GSMVX | 16.78 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity Instl | |||
CLBFX | 38.87 | 0.04 | +0.10% |
American Funds American Balanced 529F | |||
SGQIX | 46.28 | -0.03 | -0.06% |
DWS International Growth Inst |